Tower Research Capital (TRC)’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.5K | Buy |
9,324
+5,473
|
|
||||
|
2025
Q1 | $10.1K | Buy |
3,851
+338
|
|
||||
|
2024
Q4 | $12.4K | Sell |
3,513
-474
|
|
||||
|
2024
Q3 | $18.2K | Sell |
3,987
-3,143
|
|
||||
|
2024
Q2 | $31K | Sell |
7,130
-3,525
|
|
||||
|
2024
Q1 | $53.5K | Buy |
10,655
+5,137
|
|
||||
|
2023
Q4 | $34.6K | Sell |
5,518
-6,472
|
|
||||
|
2023
Q3 | $85.4K | Buy |
11,990
+11,285
|
|
||||
|
2023
Q2 | $7.18K | Sell |
705
-16,277
|
|
||||
|
2023
Q1 | $154K | Buy |
16,982
+2,533
|
|
||||
|
2022
Q4 | $104K | Buy |
14,449
+6,433
|
|
||||
|
2022
Q3 | $52K | Buy |
8,016
+1,520
|
|
||||
|
2022
Q2 | $31K | Buy |
6,496
+6,396
|
|
||||
|
2022
Q1 | $1K | Buy |
+100
|
|
||||
|
2021
Q3 | – | Sell |
-2,112
|
|
||||
|
2021
Q2 | $13K | Sell |
2,112
-621
|
|
||||
|
2021
Q1 | $18K | Sell |
2,733
-807
|
|
||||
|
2020
Q4 | $19K | Sell |
3,540
-2,015
|
|
||||
|
2020
Q3 | $41K | Sell |
5,555
-5,685
|
|
||||
|
2020
Q2 | $83K | Buy |
11,240
+9,639
|
|
||||
|
2020
Q1 | $12K | Buy |
1,601
+964
|
|
||||
|
2019
Q4 | $4K | Buy |
+637
|
|
||||
|
2019
Q3 | – | Sell |
-3,211
|
|
||||
|
2019
Q2 | $10K | Sell |
3,211
-4,235
|
|
||||
|
2019
Q1 | $22K | Buy |
7,446
+6,420
|
|
||||
|
2018
Q4 | $4K | Buy |
1,026
+751
|
|
||||
|
2018
Q3 | $2K | Sell |
275
-1,155
|
|
||||
|
2018
Q2 | $8K | Buy |
+1,430
|
|